🏗️ British Oncology is currently under development · Expected to open in Early 2027 — Dubai Healthcare City · Register Interest
🏥 British Oncology — Opening Early 2027 · Dubai Healthcare City 🎗️ First GammaPod in the Middle East — dedicated breast cancer centre ⚡ Adaptive LINAC radiotherapy · PET-CT Nuclear Medicine · Women's Cancer Centre 🌍 Serving patients from across the Gulf, Middle East and Africa 📞 enquiries@britishoncology.ae 🏥 British Oncology — Opening Early 2027 · Dubai Healthcare City 🎗️ First GammaPod in the Middle East — dedicated breast cancer centre ⚡ Adaptive LINAC radiotherapy · PET-CT Nuclear Medicine · Women's Cancer Centre 🌍 Serving patients from across the Gulf, Middle East and Africa 📞 enquiries@britishoncology.ae
Partnerships

Partner With British Oncology

We are actively building a network of institutional, clinical and commercial partnerships across the Gulf, Middle East and Africa. Whatever your organisation, we have a pathway for you.

🏛️

Government & Ministry of Health Partnerships

British Oncology is seeking formal partnerships with Ministries of Health and government health authorities across the GCC, Middle East and Africa. Our model enables governments to offer their citizens access to world-class cancer care without overseas referral costs.

What we offer: Priority patient admission, government billing, dedicated national patient pathways, joint oncology training programmes, and the potential for national screening programme partnerships through our early detection clinics.

Government Enquiry
🏥

Regional Hospital & Clinical Partnerships

We partner with hospitals across the region to provide their patients with access to oncology services they cannot deliver themselves — particularly GammaPod breast radiosurgery, PET-CT staging and adaptive LINAC radiotherapy.

Partnership options: Formal referral agreement, MDT participation, shared care protocols, clinical liaison arrangement, and tiered commission structures for high-volume referring centres.

Hospital Partnership
📋

Insurance Company & TPA Agreements

British Oncology will establish direct billing relationships with major health insurers across the GCC and internationally. Our transparent treatment protocols, British clinical standards and DHA licensing make us an ideal preferred provider partner.

For insurers: Direct billing, transparent pricing schedules, pre-authorisation pathway, treatment outcome reporting, and early intervention programmes to reduce long-term claims costs through early detection.

Insurance Enquiry
✈️

Medical Tourism Agency Partnerships

British Oncology is seeking accredited medical tourism agencies across Africa, South Asia and the MENA region to refer patients to our centre. As the only GammaPod centre in the region, we offer a unique, highly differentiated patient proposition.

Agent benefits: Dedicated agent portal, patient tracking, transparent fee structure, priority booking for referred patients, marketing materials and co-branded patient pathway documents.

Tourism Agent Enquiry
👨‍⚕️

Referring Doctor Programme

We work directly with oncologists, surgeons and general physicians across the region to provide seamless referral pathways for their patients. Our multidisciplinary team will respond to referrals within 24 hours.

Referral pathway: Online referral form, direct MDT access, 24-hour response commitment, shared electronic medical records, regular clinical updates and CPD webinars on GammaPod and adaptive RT.

Clinical Referral
📈

Investment Partnership

British Oncology is seeking strategic investment partners to support the development and operation of the centre. We welcome sovereign wealth funds, healthcare-focused private equity, family offices and strategic industrial investors.

Investment proposition: First-mover advantage, Dubai Healthcare City location, world-first GammaPod positioning, scalable model with regional expansion opportunities. Detailed IM available under NDA.

Investor Information